{"id":"https://openalex.org/W2016107722","doi":"https://doi.org/10.1046/j.1365-2893.1998.00113.x","title":"Leucocyte interferon\u2010\u03b1 retreatment for chronic hepatitis C patients previously intolerant to other interferons","display_name":"Leucocyte interferon\u2010\u03b1 retreatment for chronic hepatitis C patients previously intolerant to other interferons","publication_year":1998,"publication_date":"1998-09-01","ids":{"openalex":"https://openalex.org/W2016107722","doi":"https://doi.org/10.1046/j.1365-2893.1998.00113.x","mag":"2016107722","pmid":"https://pubmed.ncbi.nlm.nih.gov/9795917"},"language":"en","primary_location":{"id":"doi:10.1046/j.1365-2893.1998.00113.x","doi":"https://doi.org/10.1046/j.1365-2893.1998.00113.x","is_oa":false,"landing_page_url":"https://doi.org/10.1046/j.1365-2893.1998.00113.x","pdf_url":null,"source":{"id":"https://openalex.org/S164225461","display_name":"Journal of Viral Hepatitis","issn_l":"1352-0504","issn":["1352-0504","1365-2893"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Viral Hepatitis","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5089456583","display_name":"Bruno Santi Cacopardo","orcid":"https://orcid.org/0000-0002-7465-0714","observed_orcids":["https://orcid.org/0000-0002-7465-0714"]},"institutions":[{"id":"https://openalex.org/I39063666","display_name":"University of Catania","ror":"https://ror.org/03a64bh57","country_code":"IT","type":"education","lineage":["https://openalex.org/I39063666"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"B. Cacopardo","raw_affiliation_strings":["Infectious Diseases Institute, University of Catania, Italy","Infectious Diseases Institute, University of Catania, Catania, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Infectious Diseases Institute, University of Catania, Italy","institution_ids":["https://openalex.org/I39063666"]},{"raw_affiliation_string":"Infectious Diseases Institute, University of Catania, Catania, Italy","institution_ids":["https://openalex.org/I39063666"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014375166","display_name":"Francesco Benanti","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I39063666","display_name":"University of Catania","ror":"https://ror.org/03a64bh57","country_code":"IT","type":"education","lineage":["https://openalex.org/I39063666"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"F. Benanti","raw_affiliation_strings":["Infectious Diseases Institute, University of Catania, Catania, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Infectious Diseases Institute, University of Catania, Catania, Italy","institution_ids":["https://openalex.org/I39063666"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072679182","display_name":"G. Brancati","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I39063666","display_name":"University of Catania","ror":"https://ror.org/03a64bh57","country_code":"IT","type":"education","lineage":["https://openalex.org/I39063666"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"G. Brancati","raw_affiliation_strings":["Infectious Diseases Institute, University of Catania, Catania, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Infectious Diseases Institute, University of Catania, Catania, Italy","institution_ids":["https://openalex.org/I39063666"]}]},{"author_position":"middle","author":{"id":null,"display_name":"F. Romano","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I39063666","display_name":"University of Catania","ror":"https://ror.org/03a64bh57","country_code":"IT","type":"education","lineage":["https://openalex.org/I39063666"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"F. Romano","raw_affiliation_strings":["Infectious Diseases Institute, University of Catania, Catania, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Infectious Diseases Institute, University of Catania, Catania, Italy","institution_ids":["https://openalex.org/I39063666"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5087781272","display_name":"A Nunnari","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I39063666","display_name":"University of Catania","ror":"https://ror.org/03a64bh57","country_code":"IT","type":"education","lineage":["https://openalex.org/I39063666"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"A. Nunnari","raw_affiliation_strings":["Infectious Diseases Institute, University of Catania, Catania, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Infectious Diseases Institute, University of Catania, Catania, Italy","institution_ids":["https://openalex.org/I39063666"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5089456583"],"corresponding_institution_ids":["https://openalex.org/I39063666"],"apc_list":{"value":4610,"currency":"USD","value_usd":4610},"apc_paid":null,"fwci":0.9705,"has_fulltext":false,"cited_by_count":23,"citation_normalized_percentile":{"value":0.77132146,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"5","issue":"5","first_page":"333","last_page":"339"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10151","display_name":"Hepatitis C virus research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10151","display_name":"Hepatitis C virus research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11495","display_name":"Animal Virus Infections Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1103","display_name":"Animal Science and Zoology"},"field":{"id":"https://openalex.org/fields/11","display_name":"Agricultural and Biological Sciences"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10340","display_name":"Hepatitis B Virus Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chronic-hepatitis-c","display_name":"chronic hepatitis C","score":0.9570000171661377},{"id":"https://openalex.org/keywords/interferon-alpha","display_name":"interferon-alpha","score":0.5849999785423279},{"id":"https://openalex.org/keywords/leukocyte-interferon","display_name":"leukocyte interferon","score":0.8289999961853027},{"id":"https://openalex.org/keywords/retreatment","display_name":"retreatment","score":0.8140000104904175},{"id":"https://openalex.org/keywords/lymphoblastoid-interferon","display_name":"lymphoblastoid interferon","score":0.9509999752044678},{"id":"https://openalex.org/keywords/treatment-tolerability","display_name":"treatment tolerability","score":0.7440000176429749},{"id":"https://openalex.org/keywords/hcv-rna-clearance","display_name":"HCV RNA clearance","score":0.7300000190734863},{"id":"https://openalex.org/keywords/long-term-response","display_name":"long-term response","score":0.5419999957084656},{"id":"https://openalex.org/keywords/leukopenia","display_name":"leukopenia","score":0.7070000171661377},{"id":"https://openalex.org/keywords/autoimmunity","display_name":"autoimmunity","score":0.7360000014305115},{"id":"https://openalex.org/keywords/interferon-side-effects","display_name":"interferon adverse effects","score":0.4869999885559082}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.852352499961853},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.6848605871200562},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.6511772274971008},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.61857008934021},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5744625926017761},{"id":"https://openalex.org/C2780966972","wikidata":"https://www.wikidata.org/wiki/Q86","display_name":"Headaches","level":2,"score":0.563271701335907},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.5003018379211426},{"id":"https://openalex.org/C2776178377","wikidata":"https://www.wikidata.org/wiki/Q188269","display_name":"Interferon","level":2,"score":0.4980132579803467},{"id":"https://openalex.org/C2909179924","wikidata":"https://www.wikidata.org/wiki/Q6046488","display_name":"Alpha interferon","level":3,"score":0.4945206344127655},{"id":"https://openalex.org/C45189115","wikidata":"https://www.wikidata.org/wiki/Q502159","display_name":"Serology","level":3,"score":0.48091432452201843},{"id":"https://openalex.org/C113842279","wikidata":"https://www.wikidata.org/wiki/Q1873857","display_name":"Lymphoblast","level":3,"score":0.4804953336715698},{"id":"https://openalex.org/C2776029263","wikidata":"https://www.wikidata.org/wiki/Q131742","display_name":"Hepatitis","level":2,"score":0.41130390763282776},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.20578926801681519},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.12452954053878784},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007372","descriptor_name":"Interferons","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016898","descriptor_name":"Interferon-alpha","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D016898","descriptor_name":"Interferon-alpha","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D019698","descriptor_name":"Hepatitis C, Chronic","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1046/j.1365-2893.1998.00113.x","doi":"https://doi.org/10.1046/j.1365-2893.1998.00113.x","is_oa":false,"landing_page_url":"https://doi.org/10.1046/j.1365-2893.1998.00113.x","pdf_url":null,"source":{"id":"https://openalex.org/S164225461","display_name":"Journal of Viral Hepatitis","issn_l":"1352-0504","issn":["1352-0504","1365-2893"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Viral Hepatitis","raw_type":"journal-article"},{"id":"pmid:9795917","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9795917","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of viral hepatitis","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":19,"referenced_works":["https://openalex.org/W161749255","https://openalex.org/W1486067148","https://openalex.org/W1967606349","https://openalex.org/W1969164980","https://openalex.org/W1971845865","https://openalex.org/W1980658265","https://openalex.org/W2014967654","https://openalex.org/W2019752974","https://openalex.org/W2033950304","https://openalex.org/W2043144554","https://openalex.org/W2058072615","https://openalex.org/W2060024172","https://openalex.org/W2074984401","https://openalex.org/W2083529479","https://openalex.org/W2087704532","https://openalex.org/W2120692382","https://openalex.org/W2135810769","https://openalex.org/W2318639814","https://openalex.org/W2331029942"],"related_works":["https://openalex.org/W2082056735","https://openalex.org/W2417933197","https://openalex.org/W308502956","https://openalex.org/W2136855565","https://openalex.org/W2402133131","https://openalex.org/W2408922186","https://openalex.org/W2026473365","https://openalex.org/W2042319108","https://openalex.org/W2461984155","https://openalex.org/W2402155291"],"abstract_inverted_index":{"The":[0,150],"activity":[1],"and":[2,77,94,131,140],"tolerability":[3],"of":[4,27,40,55,83,106,119,137,153,166,174,193,205],"a":[5,25,37,53,74,184],"retreatment":[6],"cycle":[7],"with":[8,147,197,217,220],"leucocyte":[9,154,212],"interferon-alpha":[10],"(IFN-alpha)":[11],"(6":[12],"million":[13],"units":[14],"(MU)":[15],"three":[16],"times":[17],"weekly":[18],"for":[19,126],"12":[20,104],"months)":[21],"was":[22,169],"evaluated":[23],"in":[24,98,158,215],"group":[26],"22":[28,192],"hepatitis":[29],"C":[30],"patients":[31,44,66,100,109,121,159,177,195,216],"who":[32,178],"had":[33,73,81,183],"been":[34],"intolerant":[35,161],"to":[36,51,60,144,162,189],"previous":[38,221],"course":[39],"lymphoblastoid":[41,148,167,198],"IFN-alpha.":[42,149,199],"Seven":[43],"(31%)":[45],"discontinued":[46],"the":[47,69,113,135,163,175,180],"new":[48],"therapy":[49],"owing":[50],"either":[52],"lack":[54],"response":[56,76,115],"(six":[57],"patients)":[58],"or":[59,207],"severe":[61,185],"leucopenia":[62],"(one":[63],"patient).":[64],"Fifteen":[65],"(68%)":[67],"completed":[68,179],"12-month":[70,181],"treatment:":[71],"all":[72],"biochemical":[75,114],"10":[78],"(45%)":[79],"also":[80,124],"disappearance":[82],"serum":[84,127],"HCV":[85,128],"RNA":[86],"(complete":[87],"response).":[88],"Mild":[89],"adverse":[90,186],"reactions":[91],"(fever,":[92],"headaches":[93],"diarrhoea)":[95],"were":[96,123,142,202],"seen":[97,146],"these":[99,120],"during":[101],"retreatment.":[102],"After":[103],"months":[105],"follow-up,":[107,141],"11":[108],"(50%)":[110],"still":[111],"maintained":[112],"(long-term":[116],"response);":[117],"seven":[118],"(32%)":[122],"negative":[125],"RNA.":[129],"Biochemical":[130],"complete":[132],"responses,":[133],"at":[134],"end":[136],"both":[138],"treatment":[139,182],"similar":[143],"those":[145],"full":[151],"dose":[152],"IFN-alpha,":[155,168,213],"when":[156],"used":[157],"previously":[160],"same":[164],"dosage":[165],"better":[170],"tolerated:":[171],"only":[172],"one":[173],"15":[176],"event":[187],"leading":[188],"withdrawal":[190],"vs":[191],"68":[194],"treated":[196],"Furthermore,":[200],"there":[201],"no":[203],"manifestations":[204],"serological":[206],"clinical":[208],"autoimmunity":[209],"caused":[210],"by":[211],"even":[214],"autoantibodies":[218],"associated":[219],"IFN":[222],"therapy.":[223]},"counts_by_year":[{"year":2015,"cited_by_count":1},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}